OA-4 Inhibits Osteoclast Formation and Bone Resorption via Suppressing RANKL Induced P38 Signaling Pathway

E-ISSN： 1875-533x|21|5|641-649

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.5, 2014-02, pp. : 641-649

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

3'4'7-Trihydroxyflavone inhibits RANKL-induced osteoclast formation

By Kang Ju-Hee Lee Juhyun Moon Miran Yim Mijung

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 10, 2015-10 ,pp. : 661-667

Govi-Verlag

Access to resources Recommend Favorite

Nifedipine inhibits angiotensin II-induced cardiac fibrosis via downregulating Nox4-derived ROS generation and suppressing ERK1/2, JNK signaling pathways

By Jia Yanyan Xu Jian Yu Yang Guo Jinlei Liu Peiqing Chen Shaorui Jiang Jianmin

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 6, 2013-06 ,pp. : 435-441

Govi-Verlag

Access to resources Recommend Favorite

Triptolide alleviates isoprenaline-induced cardiac remodeling in rats via TGF-β1/Smad3 and p38 MAPK signaling pathway

By Liu Mao Chen Jian Huang Yongquan Ke Jianting Li Lingling Huang Dan Wu Wei

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 4, 2015-04 ,pp. : 244-250

Govi-Verlag

Access to resources Recommend Favorite

siRNA Knock-Down of RANK Signaling to Control Osteoclast-Mediated Bone Resorption

By Wang Yuwei Grainger David

Pharmaceutical Research, Vol. 27, Iss. 7, 2010-07 ,pp. : 1273-1284

Springer Publishing Company

Access to resources Recommend Favorite

Endogenous BNP attenuates cardiomyocyte hypertrophy induced by Ang II via p38 MAPK/Smad signaling

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 11, 2014-11 ,pp. : 833-837

Govi-Verlag

Access to resources Recommend Favorite